Mereo BioPharma Group plc

NasdaqCM:MREO 株式レポート

時価総額:US$657.4m

Mereo BioPharma Group 所有権

大株主は誰で、インサイダーは売買しているのか?


最近のインサイダー取引

NasdaqCM:MREO 企業または個人による最近のインサイダー取引
日付価値名称エンティティ役割株式最高価格
13 Sep 24SellUS$121,693Christine FoxIndividual28,286US$4.47
13 Sep 24SellUS$133,051Charles SermonIndividual30,926US$4.47
13 Sep 24SellUS$69,477John LewickiIndividual16,149US$4.47
13 Sep 24SellUS$381,423Denise Scots-KnightIndividual88,657US$4.47
13 Sep 24SellUS$637,203Alexandra Hughes-WilsonIndividual148,110US$4.47
26 Jun 24SellUS$115,369Alexandra Hughes-WilsonIndividual33,102US$3.69
26 Jun 24SellUS$463,487Denise Scots-KnightIndividual132,985US$3.69
26 Jun 24SellUS$147,876Christine FoxIndividual42,429US$3.69
26 Jun 24SellUS$84,427John LewickiIndividual24,224US$3.69
26 Jun 24SellUS$161,678Charles SermonIndividual46,389US$3.69
17 Nov 23BuyUS$984,120Rubric Capital Management LPCompany475,666US$2.08
13 Nov 23BuyUS$2,966Rubric Capital Management LPCompany1,440US$2.06
10 Nov 23BuyUS$720,643Rubric Capital Management LPCompany351,639US$2.06
07 Nov 23BuyUS$899,742Rubric Capital Management LPCompany437,724US$2.06

インサイダー取引量

インサイダー購入: MREO insiders have only sold shares in the past 3 months.


所有権の内訳

MREO の所有者構成は?
オーナータイプ株式数所有比率
個人インサイダー5,066,4713.3%
一般市民40,511,80026.4%
ヘッジファンド51,525,04233.5%
機関56,501,75436.8%

株式の希薄化: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.3%.


上位株主

25 上位株主69.76 %を所有。
所有権名称株式現在の価値変化率ポートフォリオ
14.1%
Rubric Capital Management LP
21,697,347US$92.9m8.8%1.49%
7.68%
Adage Capital Management, L.P.
11,791,310US$50.5m26.4%0.09%
6.04%
Rock Springs Capital Management LP
9,283,492US$39.7m14%1.17%
5.7%
Mangrove Partners IM, LLC
8,752,893US$37.5m0%3.02%
5.17%
Janus Henderson Group plc
7,945,704US$34.0m0.82%0.01%
4.37%
Deerfield Management Company, L.P. Series C
6,710,429US$28.7m0%0.46%
3.26%
683 Capital Management, LLC
5,000,000US$21.4m-13%1.95%
3.06%
Alkeon Capital Management, LLC
4,698,100US$20.1m10.9%0.13%
2.87%
Frazier Life Sciences Management, LP
4,401,371US$18.8m0%0.77%
2.17%
Clearline Capital LP
3,326,718US$14.2m0%1.21%
2.08%
Millennium Management LLC
3,201,705US$13.7m46.9%0.01%
1.92%
Denise Scots-Knight
2,942,410US$12.6m3.5%データなし
1.7%
Tejara Capital Limited., Asset Management Arm
2,615,458US$11.2m5.88%4.14%
1.63%
Goldman Sachs Group, Investment Banking and Securities Investments
2,507,513US$10.7m11.8%データなし
1.16%
Integral Health Asset Management, LLC
1,775,000US$7.6m86.8%0.71%
1.15%
Renaissance Technologies LLC
1,762,003US$7.5m5.36%0.01%
0.82%
Perceptive Advisors LLC
1,253,250US$5.4m0%0.11%
0.81%
Soleus Capital Management, L.P.
1,246,953US$5.3m-52.4%0.4%
0.74%
Marshall Wace LLP
1,144,051US$4.9m0%0.01%
0.62%
Nationwide Fund Advisors
959,467US$4.1m0%0.03%
0.58%
CHI Advisors LLC
897,809US$3.8m0%1.24%
0.58%
Charles Sermon
893,041US$3.8m4.04%データなし
0.55%
Susquehanna International Group, LLP, Asset Management Arm
840,264US$3.6m-48.1%0.01%
0.55%
Tema Global Limited, Asset Management Arm
837,909US$3.6m16%1.98%
0.44%
Acuta Capital Partners, LLC
677,000US$2.9m70.2%2.01%